Company intelligence / Profile preview
MGC Pharmaceuticals
United Kingdomdata.fca.org.uk ↗
- Ownership
- Private
- Employees
- ~41
- Development stage
- Commercial
01
Overview
MGC Pharmaceuticals has developed a portfolio of plant-inspired medicines with three flagship products—CannEpil®, CimetrA®, CogniCann®—in late-stage clinical development. CannEpil® is used for refractory epilepsy/cerebral palsy; CimetrA® for acute lung injury/COVID symptoms; CogniCann® for dementia/Alzheimer's. The company leverages real-world data from early access programs to support regulatory filings. Additional pipeline assets target oncology (glioblastoma) and autoimmune/inflammatory diseases.
- Therapeutic areas
- GastroenterologyPulmonologyImmunologyOncologyNeurologyInfectious Diseases
- Modalities
- Small moleculePlant-derived medicineNutraceutical
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
AMC in the US market for distribution of plant-based productsacademic institutions in Europe and Israel
Beyond the preview
Go deeper on MGC Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MGC Pharmaceuticals.